Karyopharm Therapeutics


Ebit Cambiamento Data
AbbVie USD 5.72B 69M 2025-06
Abbott USD 2.07B 105M 2025-06
Amgen USD 2.26B 1.34B 2025-06
AstraZeneca USD 3.51B 1.3B 2025-06
Bristol-Myers Squibb USD 2.26B 1.92B 2025-06
Eli Lilly USD 7.02B 3.32B 2025-06
GlaxoSmithKline GBP 2.07B 462M 2025-06
Incyte USD 310.82M 27.18M 2025-06
J&J USD 6.94B 443M 2025-06
MacroGenics USD -35344000 17.49M 2025-06
Merck USD 6.36B 149M 2025-06
Novartis USD -9190000000 13.87B 2025-06
Novartis USD 4.82B 39M 2025-06
Pfizer USD 2.6B 3.33B 2025-06
Regeneron Pharmaceuticals USD 1.52B 608.6M 2025-06
Roche Holding CHF 11.29B 2.68B 2024-06
Takeda JPY 257.79B 387.52B 2025-06
Tectonic Therapeutic USD -22332000 8.34M 2025-06
TG Therapeutics USD 34.84M 22.62M 2025-06
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06
Xencor USD -22832000 16.77M 2025-06


Karyopharm Therapeutics - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.